Susan Silbermann

Susan Silbermann is President and General Manager, Pfizer Vaccines, which brings vaccines to patients that significantly improve their lives. In this role, Silbermann oversees a global business and is responsible for the commercial development of an exciting pipeline portfolio of preventative and therapeutic vaccines. Prior to this position, she was the regional president of Latin America, managing Pfizer’s pharmaceutical operations in more than 20 countries each with diverse health needs and priorities. Silbermann holds a seat on the International Federation of Pharmaceutical Manufacturers & Associations Vaccine CEO Steering Committee. In addition, she serves on the corporate advisory board for the Johns Hopkins University Carey Business School. Silbermann has a B.S. in biology and French from Tufts University, and a joint M.B.A./M.A. degree from the Stern Graduate School of Business and the Institute of French Studies at New York University.